Spark and ADHD

The Center for Family Medicine published a research article about the comparison of the neuropsychological effects of Methylphenidate and Spark on children with attention-deficit hyperactivity disorder.

Methylphenidate is the most commonly prescribed psychostimulant and is indicated in the treatment of attention-deficit hyperactivity disorder and narcolepsy. In North America it is most commonly known as the brand name Ritalin.

The research article can be read here.

If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.

Comments

No comments yet.

Leave a comment

(required)

(required)